Literature DB >> 30195268

Papilla reconstruction: Interdisciplinary consideration for clinical success.

João Carnio1, Anna Tereza Carnio2.   

Abstract

One of the most difficult achievements in the periodontal therapy is the reconstruction of interdental papilla that has been lost by periodontal disease. The poor esthetic appearance caused by the "black triangle," especially in the maxillary anterior region has been a concern for both patients and professionals. However, when the papilla destruction is followed by loss of contact point, the use of different specialties is usually necessary to restore the interproximal embrasure. This clinical case report describes an interdisciplinary (periodontic-orthodontic-restorative) approach for the treatment of a patient with severe case of papilla destruction in an esthetic zone. The patient's esthetic expectations for the anterior maxilla were met through phase I treatment, including the surgical reconstruction of the papillary complex and the orthodontic movement to restore the contact point. However, after the initial treatment was successfully concluded, the long-term stability of the result was compromised as the intercommunication among the specialists was not coordinated. CLINICAL SIGNIFICANCE: The treatment plan that involves interdisciplinary teamwork should be followed by an understanding about the principles of the specialties as well the intercommunication among specialists.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  esthetics; gingival reconstruction; inter disciplinary dental treatment; papilla; periodontics

Mesh:

Year:  2018        PMID: 30195268     DOI: 10.1111/jerd.12411

Source DB:  PubMed          Journal:  J Esthet Restor Dent        ISSN: 1496-4155            Impact factor:   2.843


  1 in total

1.  Hyaluronic acid vs. physiological saline for enlarging deficient gingival papillae: a randomized controlled clinical trial and an in vitro study.

Authors:  Jing Ni; Zhe Zhong; Yifan Wu; Rong Shu; Yiqun Wu; Chaolun Li
Journal:  Ann Transl Med       Date:  2021-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.